WallStSmart

8x8 Inc Common Stock (EGHT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

8x8 Inc Common Stock generates 181% more annual revenue ($727.55M vs $258.90M). EGHT leads profitability with a -0.5% profit margin vs -15.5%. EGHT earns a higher WallStSmart Score of 56/100 (C).

EGHT

Buy

56

out of 100

Grade: C

Growth: 6.0Profit: 3.5Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EGHT.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EGHT3 strengths · Avg: 9.3/10
PEG RatioValuation
0.4810/10

Growing faster than its price suggests

EPS GrowthGrowth
83.4%10/10

Earnings expanding 83.4% YoY

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

EGHT4 concerns · Avg: 2.5/10
Revenue GrowthGrowth
3.4%4/10

3.4% revenue growth

Market CapQuality
$266.10M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-3.0%2/10

ROE of -3.0% — below average capital efficiency

Profit MarginProfitability
-0.5%1/10

Currently unprofitable

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : EGHT

The strongest argument for EGHT centers on PEG Ratio, EPS Growth, Price/Book. PEG of 0.48 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : EGHT

The primary concerns for EGHT are Revenue Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

EGHT profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

EGHT carries more volatility with a beta of 1.81 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

EGHT scores higher overall (56/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

8x8 Inc Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

8x8, Inc. provides enterprise-class voice, video, chat, contact center and contact center application programmable interface (API) software solutions for small and medium-sized businesses, medium-sized and large businesses, government agencies, and other organizations to world level. The company is headquartered in Campbell, California.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?